Skip to main content
Top
Published in: European Radiology 1/2019

01-01-2019 | Magnetic Resonance

Pre-TACE kurtosis of ADCtotal derived from histogram analysis for diffusion-weighted imaging is the best independent predictor of prognosis in hepatocellular carcinoma

Authors: Li-Fang Wu, Sheng-Xiang Rao, Peng-Ju Xu, Li Yang, Cai-Zhong Chen, Hao Liu, Jian-Feng Huang, Cai-Xia Fu, Alice Halim, Meng-Su Zeng

Published in: European Radiology | Issue 1/2019

Login to get access

Abstract

Purpose

To determine the feasibility of pre-TACE IVIM imaging based on histogram analysis for predicting prognosis in the treatment of unresectable hepatocellular carcinoma (HCC).

Materials and methods

Fifty-five patients prospectively underwent 1.5T MRI 1 week before TACE. Histogram metrics for IVIM parameters and ADCs maps between responders and non-responders with mRECIST assessment were compared. Kaplan–Meier, log-rank tests and Cox proportional hazard regression model were used to correlate variables with time to progression (TTP).

Results

Mean (p = 0.022), median (p = 0.043), and 25th percentile (p < 0.001) of perfusion fraction (PF), mean (p < 0.001), median (p < 0.001), 25th percentile (p < 0.001) and 75th percentile (p = 0.001) of ADC(0,500), mean (p = 0.005), median (p = 0.008) and 25th percentile (p = 0.039) of ADCtotal were higher, while skewness and kurtosis of PF (p = 0.001, p = 0.005, respectively), kurtosis of ADC(0,500) and ADCtotal (p = 0.005, p = 0.001, respectively) were lower in responders compared to non-responders. Multivariable analysis demonstrated that mRECIST was associated with TTP independently, and kurtosis of ADCtotal had the best predictive performance for disease progression.

Conclusion

Pre-TACE kurtosis of ADCtotal is the best independent predictor for TTP.

Key Points

mRECIST was associated with TTP independently.
• Lower kurtosis and higher mean for ADCs tend to have good response.
• Pre-TACE kurtosis of ADC total is the best independent predictor for TTP.
Literature
1.
go back to reference Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245–1255CrossRef Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245–1255CrossRef
2.
go back to reference European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943CrossRef
3.
go back to reference Reig M, Darnell A, Forner A, Rimola J, Ayuso C, Bruix J (2014) Systemic therapy for hepatocellular carcinoma: the issue of treatment stage migration and registration of progression using the BCLC-refined RECIST. Semin Liver Dis 34:444–455CrossRef Reig M, Darnell A, Forner A, Rimola J, Ayuso C, Bruix J (2014) Systemic therapy for hepatocellular carcinoma: the issue of treatment stage migration and registration of progression using the BCLC-refined RECIST. Semin Liver Dis 34:444–455CrossRef
4.
go back to reference Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022CrossRef Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022CrossRef
5.
go back to reference Wu L, Xu P, Rao S et al (2017) ADCtotal ratio and D ratio derived from intravoxel incoherent motion early after TACE are independent predictors for survival in hepatocellular carcinoma. J Magn Reson Imaging 46:820–830CrossRef Wu L, Xu P, Rao S et al (2017) ADCtotal ratio and D ratio derived from intravoxel incoherent motion early after TACE are independent predictors for survival in hepatocellular carcinoma. J Magn Reson Imaging 46:820–830CrossRef
6.
go back to reference Lin M, Tian MM, Zhang WP, Xu L, Jin P (2016) Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma. Onco Targets Ther 9:7029–7037CrossRef Lin M, Tian MM, Zhang WP, Xu L, Jin P (2016) Predictive values of diffusion-weighted imaging and perfusion-weighted imaging in evaluating the efficacy of transcatheter arterial chemoembolization for hepatocellular carcinoma. Onco Targets Ther 9:7029–7037CrossRef
7.
go back to reference Park YS, Lee CH, Kim JH et al (2014) Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result. Magn Reson Imaging 32:638–646CrossRef Park YS, Lee CH, Kim JH et al (2014) Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result. Magn Reson Imaging 32:638–646CrossRef
8.
go back to reference Liang HY, Huang YQ, Yang ZX, Ying-Ding ZMS, Rao SX (2016) Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases. Eur Radiol 26:2009–2018CrossRef Liang HY, Huang YQ, Yang ZX, Ying-Ding ZMS, Rao SX (2016) Potential of MR histogram analyses for prediction of response to chemotherapy in patients with colorectal hepatic metastases. Eur Radiol 26:2009–2018CrossRef
9.
go back to reference Guo Y, Kong QC, Zhu YQ et al (2017) Whole-lesion histogram analysis of the apparent diffusion coefficient: Evaluation of the correlation with subtypes of mucinous breast carcinoma. J Magn Reson Imaging 47:391–400CrossRef Guo Y, Kong QC, Zhu YQ et al (2017) Whole-lesion histogram analysis of the apparent diffusion coefficient: Evaluation of the correlation with subtypes of mucinous breast carcinoma. J Magn Reson Imaging 47:391–400CrossRef
10.
go back to reference Bougias H, Ghiatas A, Priovolos D, Veliou K, Christou A (2017) Whole-lesion histogram analysis metrics of the apparent diffusion coefficient as a marker of breast lesions characterization at 1.5 T. Radiography (Lond) 23:e41–e46CrossRef Bougias H, Ghiatas A, Priovolos D, Veliou K, Christou A (2017) Whole-lesion histogram analysis metrics of the apparent diffusion coefficient as a marker of breast lesions characterization at 1.5 T. Radiography (Lond) 23:e41–e46CrossRef
11.
go back to reference Donati OF, Mazaheri Y, Afaq A et al (2014) Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology 271:143–152CrossRef Donati OF, Mazaheri Y, Afaq A et al (2014) Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology 271:143–152CrossRef
12.
go back to reference Hu XX, Yang ZX, Liang HY et al (2017) Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index. J Magn Reson Imaging 46:383–392CrossRef Hu XX, Yang ZX, Liang HY et al (2017) Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index. J Magn Reson Imaging 46:383–392CrossRef
13.
go back to reference Yoon JH, Lee JM, Yu MH, Kiefer B, Han JK, Choi BI (2014) Evaluation of hepatic focal lesions using diffusion-weighted MR imaging: comparison of apparent diffusion coefficient and intravoxel incoherent motion-derived parameters. J Magn Reson Imaging 39:276–285CrossRef Yoon JH, Lee JM, Yu MH, Kiefer B, Han JK, Choi BI (2014) Evaluation of hepatic focal lesions using diffusion-weighted MR imaging: comparison of apparent diffusion coefficient and intravoxel incoherent motion-derived parameters. J Magn Reson Imaging 39:276–285CrossRef
14.
go back to reference Makuuchi M, Kokudo N, Arii S et al (2008) Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 38:37–51CrossRef Makuuchi M, Kokudo N, Arii S et al (2008) Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res 38:37–51CrossRef
15.
go back to reference Nouso K, Tanaka H, Uematsu S et al (2008) Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances. J Gastroenterol Hepatol 23:437–444CrossRef Nouso K, Tanaka H, Uematsu S et al (2008) Cost-effectiveness of the surveillance program of hepatocellular carcinoma depends on the medical circumstances. J Gastroenterol Hepatol 23:437–444CrossRef
16.
go back to reference Gillmore R, Stuart S, Kirkwood A et al (2011) EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J Hepatol 55:1309–1316CrossRef Gillmore R, Stuart S, Kirkwood A et al (2011) EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization. J Hepatol 55:1309–1316CrossRef
17.
go back to reference Vandecaveye V, Michielsen K, De Keyzer F et al (2014) Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome. Radiology 270:747–757CrossRef Vandecaveye V, Michielsen K, De Keyzer F et al (2014) Chemoembolization for hepatocellular carcinoma: 1-month response determined with apparent diffusion coefficient is an independent predictor of outcome. Radiology 270:747–757CrossRef
18.
go back to reference Mannelli L, Kim S, Hajdu CH, Babb JS, Taouli B (2013) Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience. Eur J Radiol 82:577–582CrossRef Mannelli L, Kim S, Hajdu CH, Babb JS, Taouli B (2013) Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: Prediction and assessment of response to transarterial chemoembolization. Preliminary experience. Eur J Radiol 82:577–582CrossRef
19.
go back to reference Dong S, Ye XD, Yuan Z, Xu LC, Xiao XS (2012) Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization. Eur J Radiol 81:472–477CrossRef Dong S, Ye XD, Yuan Z, Xu LC, Xiao XS (2012) Relationship of apparent diffusion coefficient to survival for patients with unresectable primary hepatocellular carcinoma after chemoembolization. Eur J Radiol 81:472–477CrossRef
20.
go back to reference Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52–60CrossRef Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52–60CrossRef
21.
go back to reference Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430CrossRef Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421–430CrossRef
22.
go back to reference Woo S, Lee JM, Yoon JH, Joo I, Han JK, Choi BI (2014) Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade. Radiology 270:758–767CrossRef Woo S, Lee JM, Yoon JH, Joo I, Han JK, Choi BI (2014) Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade. Radiology 270:758–767CrossRef
23.
go back to reference Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Araki T (2013) Intravoxel incoherent motion imaging of focal hepatic lesions. J Magn Reson Imaging 37:1371–1376CrossRef Ichikawa S, Motosugi U, Ichikawa T, Sano K, Morisaka H, Araki T (2013) Intravoxel incoherent motion imaging of focal hepatic lesions. J Magn Reson Imaging 37:1371–1376CrossRef
24.
go back to reference Chandarana H, Lee VS, Hecht E, Taouli B, Sigmund EE (2011) Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Invest Radiol 46:285–291CrossRef Chandarana H, Lee VS, Hecht E, Taouli B, Sigmund EE (2011) Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Invest Radiol 46:285–291CrossRef
25.
go back to reference Lewin M, Fartoux L, Vignaud A, Arrive L, Menu Y, Rosmorduc O (2011) The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol 21:281–290CrossRef Lewin M, Fartoux L, Vignaud A, Arrive L, Menu Y, Rosmorduc O (2011) The diffusion-weighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol 21:281–290CrossRef
26.
go back to reference Guan Y, Shi H, Chen Y et al (2016) Whole-Lesion Histogram Analysis of Apparent Diffusion Coefficient for the Assessment of Cervical Cancer. J Comput Assist Tomogr 40:212–217CrossRef Guan Y, Shi H, Chen Y et al (2016) Whole-Lesion Histogram Analysis of Apparent Diffusion Coefficient for the Assessment of Cervical Cancer. J Comput Assist Tomogr 40:212–217CrossRef
27.
go back to reference Zhang Y, Chen J, Liu S et al (2017) Assessment of histological differentiation in gastric cancers using whole-volume histogram analysis of apparent diffusion coefficient maps. J Magn Reson Imaging 45:440–449CrossRef Zhang Y, Chen J, Liu S et al (2017) Assessment of histological differentiation in gastric cancers using whole-volume histogram analysis of apparent diffusion coefficient maps. J Magn Reson Imaging 45:440–449CrossRef
28.
go back to reference Choi Y, Kim SH, Youn IK, Kang BJ, Park WC, Lee A (2017) Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype. PLoS One 12:e177903 Choi Y, Kim SH, Youn IK, Kang BJ, Park WC, Lee A (2017) Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype. PLoS One 12:e177903
29.
go back to reference Yoon SH, Park CM, Park SJ, Yoon JH, Hahn S, Goo JM (2016) Tumor Heterogeneity in Lung Cancer: Assessment with Dynamic Contrast-enhanced MR Imaging. Radiology 280:940–948CrossRef Yoon SH, Park CM, Park SJ, Yoon JH, Hahn S, Goo JM (2016) Tumor Heterogeneity in Lung Cancer: Assessment with Dynamic Contrast-enhanced MR Imaging. Radiology 280:940–948CrossRef
30.
go back to reference Davnall F, Yip CS, Ljungqvist G et al (2012) Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 3:573–589CrossRef Davnall F, Yip CS, Ljungqvist G et al (2012) Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 3:573–589CrossRef
Metadata
Title
Pre-TACE kurtosis of ADCtotal derived from histogram analysis for diffusion-weighted imaging is the best independent predictor of prognosis in hepatocellular carcinoma
Authors
Li-Fang Wu
Sheng-Xiang Rao
Peng-Ju Xu
Li Yang
Cai-Zhong Chen
Hao Liu
Jian-Feng Huang
Cai-Xia Fu
Alice Halim
Meng-Su Zeng
Publication date
01-01-2019
Publisher
Springer Berlin Heidelberg
Published in
European Radiology / Issue 1/2019
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-018-5482-3

Other articles of this Issue 1/2019

European Radiology 1/2019 Go to the issue